ABVC BioPharma, Inc. (ABVC) Q1 2026 Earnings
ABVC·Reported May 18, 2026·After market close
Diluted EPS came in at $-0.06 (+0.0% YoY).
Diluted EPS
$-0.06
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about ABVC BioPharma, Inc.'s Q1 2026 earnings report.
ABVC BioPharma, Inc. (ABVC) reported Q1 2026 earnings on May 18, 2026 after market close.
ABVC BioPharma, Inc. reported diluted EPS of $-0.06 for Q1 2026.
Compared to the same quarter a year prior, diluted EPS grew 0.0% from $-0.06.
You can read the 10-Q periodic report (0001213900-26-058104) directly on SEC EDGAR. The filing index links above go to sec.gov.